BNP Paribas Asset Management
FLGT icon

BNP Paribas Asset Management’s Fulgent Genetics FLGT Stock Holding History

BNP Paribas Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.8K Buy
803
+303
+61% +$6.58K ﹤0.01% 2154
2025
Q4 		$13K Buy
500
+48
+11% +$1.25K ﹤0.01% 2069
2025
Q3 		$10K Buy
452
+167
+59% +$3.44K ﹤0.01% 1629
2025
Q2 		$6K Buy
+285
New +$5.55K ﹤0.01% 1932

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BNP Paribas Asset Management's FLGT Position: Q1 2026 in Review

BNP Paribas Asset Management increased its Fulgent Genetics (FLGT) stake by 61% in Q1 2026, buying an estimated $6.58K and bringing the position to 803 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2154.

BNP Paribas Asset Management first reported a position in FLGT in Q2 2025 and has held it in 4 quarters since. The position peaked at $13K in Q4 2025. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • BNP Paribas Asset Management held 803 shares of Fulgent Genetics worth $12.8K as of Q1 2026.
  • BNP Paribas Asset Management bought 303 Fulgent Genetics shares in Q1 2026, an estimated $6.58K.
  • Fulgent Genetics made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #2154 holding.
  • BNP Paribas Asset Management first reported a position in Fulgent Genetics in Q2 2025 and has held it in 4 quarters since.
  • BNP Paribas Asset Management's Fulgent Genetics position peaked at $13K in Q4 2025.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.